New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy [Yahoo! Finance]
Nevro Corp. (NVRO)
Last nevro corp. earnings: 2/25 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
nevro.com/english/investors/overview/default.aspx
Company Research
Source: Yahoo! Finance
REDWOOD CITY, Calif. Oct. 29, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of new data in the Journal of Pain Research demonstrating significant, durable pain relief and long-term and clinically meaningful reductions in hemoglobin A1c (HbA1c) and weight in study participants with painful diabetic neuropathy (PDN) and Type 2 diabetes who received 10 kHz high-frequency spinal cord stimulation (SCS) therapy. Globally, the number of people with diabetes has quadrupled in the last two decades , and PDN impacts up to 25% of all people with diabetes. PDN can have significant impacts on the quality of life for people living with this condition, with symptoms like numbness, tingling/paresthesia, loss of protective sensation, impaired balance, and reduced response to sensory stimuli. Patients typically manage PDN with oral pain medicat
Show less
Read more
Impact Snapshot
Event Time:
NVRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVRO alerts
High impacting Nevro Corp. news events
Weekly update
A roundup of the hottest topics
NVRO
News
- Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progress in Regenerative Medicine [Yahoo! Finance]Yahoo! Finance
- Nevro Corp. (NYSE: NVRO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- NVRO Stock Declines Despite Positive Study Data of Nevro1 System [Yahoo! Finance]Yahoo! Finance
- New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches [Yahoo! Finance]Yahoo! Finance
- New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral ApproachesPR Newswire
NVRO
Earnings
- 11/11/24 - Beat
NVRO
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/14/24 - Form 8-K
- NVRO's page on the SEC website